Genetic Technologies Limited (ADR) (NASDAQ:GENE), a molecular diagnostics company, had an excellent session yesterday which ended with a gain of 33.51%….

Genetic Technologies Limited (ADR) (NASDAQ:GENE) released news stating that its BREVAGenplus breast cancer test will be offered at six new centers. The…

Genetic Technologies Limited (ADR) (NASDAQ:GENE) has witnessed heavy trading on its stock in the past few weeks, pushing its market valuation up nearly…

Following a week of huge gains, thinly traded nano-cap stock Genetic Technologies Limited (ADR) (NASDAQ:GENE) has tumbled again. The shares of the company…

Genetic Technologies Limited (ADR) (NASDAQ:GENE) roared and ruled on the stock exchange after announcing that new six breast cancer treatment centers will…